Brovincamine

This classification denotes a vasodilating agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AYN5T18K5R. European Medicines Agency schedules Brovincamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05935MIG. Brovincamine generally arises in the molecular formula C21H25BRN2O3. The term BROVINCAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, no. 10 1980, list 20.) BROVINCAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule brovincamine under HS 29399900 and SITC 54149. As of Q4 2014, BROVINCAMINE remains the US FDA Preferred Term for this commodity. Brovincamine bears US NLM identifiers UMLS ID C0044725 and NCI Concept Code C74419. SMILES: Brc1cc2n3c4C5N(CCCC5(CC3(O)C(=O)OC)CC)CCc4c2cc1.